Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A twist for survival and cancer progression.
Puisieux A, Valsesia-Wittmann S, Ansieau S. Puisieux A, et al. Br J Cancer. 2006 Jan 16;94(1):13-7. doi: 10.1038/sj.bjc.6602876. Br J Cancer. 2006. PMID: 16306876 Free PMC article. Review.
BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A. el-Ghissassi F, et al. Oncogene. 2002 Oct 3;21(44):6772-78. doi: 10.1038/sj.onc.1205888. Oncogene. 2002. PMID: 12360398
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.
Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A. Valsesia-Wittmann S, et al. Cancer Cell. 2004 Dec;6(6):625-30. doi: 10.1016/j.ccr.2004.09.033. Cancer Cell. 2004. PMID: 15607966
Genome-wide analysis of gene expression in neuroblastomas detected by mass screening.
Krause A, Combaret V, Iacono I, Lacroix B, Compagnon C, Bergeron C, Valsesia-Wittmann S, Leissner P, Mougin B, Puisieux A. Krause A, et al. Cancer Lett. 2005 Jul 8;225(1):111-20. doi: 10.1016/j.canlet.2004.10.035. Epub 2004 Dec 8. Cancer Lett. 2005. PMID: 15922863
[Cancer cells escape from failsafe programs in a simple Twist].
Puisieux A, Valsesia-Wittmann S. Puisieux A, et al. Bull Cancer. 2006 Mar 1;93(3):251-6. Bull Cancer. 2006. PMID: 16567311 Review. French.
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.
Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A. Ansieau S, et al. Cancer Cell. 2008 Jul 8;14(1):79-89. doi: 10.1016/j.ccr.2008.06.005. Cancer Cell. 2008. PMID: 18598946
Cancer stem cells: the emerging challenge of drug targeting.
Besançon R, Valsesia-Wittmann S, Puisieux A, Caron de Fromentel C, Maguer-Satta V. Besançon R, et al. Curr Med Chem. 2009;16(4):394-416. doi: 10.2174/092986709787315531. Curr Med Chem. 2009. PMID: 19199913 Review.
Upstream ORF affects MYCN translation depending on exon 1b alternative splicing.
Besançon R, Valsesia-Wittmann S, Locher C, Delloye-Bourgeois C, Furhman L, Tutrone G, Bertrand C, Jallas AC, Garin E, Puisieux A. Besançon R, et al. BMC Cancer. 2009 Dec 17;9:445. doi: 10.1186/1471-2407-9-445. BMC Cancer. 2009. PMID: 20017904 Free PMC article.
TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, Bénard J, Puisieux A, Marabelle A, Valsesia-Wittmann S. Selmi A, et al. Cancer Lett. 2015 Feb 1;357(1):412-418. doi: 10.1016/j.canlet.2014.11.056. Epub 2014 Dec 1. Cancer Lett. 2015. PMID: 25475555
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, Valsesia-Wittmann S, Commo F, Prada N, Poirier-Colame V, Bressac B, Cotteret S, Brugieres L, Farace F, Chaput N, Kroemer G, Valteau-Couanet D, Zitvogel L. Semeraro M, et al. Among authors: valsesia wittmann s. Sci Transl Med. 2015 Apr 15;7(283):283ra55. doi: 10.1126/scitranslmed.aaa2327. Sci Transl Med. 2015. PMID: 25877893
26 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback